DK0926137T3 - Picolinsyrederivater, der er nyttige til behandling af IL-1- og TNF-medierede sygdomme - Google Patents
Picolinsyrederivater, der er nyttige til behandling af IL-1- og TNF-medierede sygdommeInfo
- Publication number
- DK0926137T3 DK0926137T3 DK98308860T DK98308860T DK0926137T3 DK 0926137 T3 DK0926137 T3 DK 0926137T3 DK 98308860 T DK98308860 T DK 98308860T DK 98308860 T DK98308860 T DK 98308860T DK 0926137 T3 DK0926137 T3 DK 0926137T3
- Authority
- DK
- Denmark
- Prior art keywords
- methyltetrazole
- treatment
- present
- mediated diseases
- picolinic acid
- Prior art date
Links
- 108010002352 Interleukin-1 Proteins 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000001404 mediated effect Effects 0.000 title abstract 2
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical class OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 title 1
- OMAFFHIGWTVZOH-UHFFFAOYSA-N 1-methyltetrazole Chemical compound CN1C=NN=N1 OMAFFHIGWTVZOH-UHFFFAOYSA-N 0.000 abstract 2
- VRESBNUEIKZECD-UHFFFAOYSA-N 2-methyltetrazole Chemical compound CN1N=CN=N1 VRESBNUEIKZECD-UHFFFAOYSA-N 0.000 abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- -1 5-substituted picolinic acid compounds Chemical class 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003236 benzoyl group Chemical class [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
- C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IBPCT/IB97/01383 | 1997-11-04 | ||
| US09/178,949 US6034107A (en) | 1997-11-04 | 1998-10-26 | 5-Substituted picolinic acid compounds and their production process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0926137T3 true DK0926137T3 (da) | 2004-08-09 |
Family
ID=26318705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98308860T DK0926137T3 (da) | 1997-11-04 | 1998-10-29 | Picolinsyrederivater, der er nyttige til behandling af IL-1- og TNF-medierede sygdomme |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6034107A (da) |
| EP (1) | EP0926137B1 (da) |
| JP (1) | JP3337992B2 (da) |
| AT (1) | ATE266641T1 (da) |
| BR (1) | BR9804753A (da) |
| CA (1) | CA2253080C (da) |
| DE (1) | DE69823787T2 (da) |
| DK (1) | DK0926137T3 (da) |
| ES (1) | ES2218776T3 (da) |
| PT (1) | PT926137E (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6579891B1 (en) * | 1995-12-29 | 2003-06-17 | Novactyl, Inc. | Agent and method for prevention and treatment of cancer in animals |
| US6743771B2 (en) | 1995-12-29 | 2004-06-01 | Novactyl, Inc. | Methods and compositions for controlling protein assembly or aggregation |
| US6407125B1 (en) | 1995-12-29 | 2002-06-18 | Novactyl, Inc. | Pharmacological agent and method of treatment |
| US6194442B1 (en) | 1997-11-04 | 2001-02-27 | Pfizer Inc | 5-substituted picolinic acid compounds and their method of use |
| JP3337992B2 (ja) * | 1997-11-04 | 2002-10-28 | ファイザー製薬株式会社 | ５−置換ピコリン酸化合物及びその製造方法 |
| US6441009B1 (en) | 1998-08-01 | 2002-08-27 | Novactyl, Inc. | Agent and method of preventing and treating heavy metal exposure and toxicity |
| US6416979B1 (en) | 1999-12-14 | 2002-07-09 | Pfizer Inc. | 5-substituted picolinic acid compounds production by Marasmiellus sp |
| US6403618B1 (en) | 2000-02-15 | 2002-06-11 | Novactyl, Inc. | Agent and method for controlling angiogenesis |
| WO2004078751A1 (ja) | 2003-03-07 | 2004-09-16 | Kowa Co., Ltd. | ベンゾフラン誘導体 |
| AR046276A1 (es) * | 2003-10-07 | 2005-11-30 | Renovis Inc | Derivados de amida como ligandos de canales ionicos y composiciones farmaceuticas y metodos que los utilizan. |
| US7576099B2 (en) * | 2005-02-28 | 2009-08-18 | Renovis, Inc. | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| US20080300243A1 (en) * | 2005-02-28 | 2008-12-04 | Kelly Michael G | Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same |
| DE102006032589A1 (de) * | 2006-07-13 | 2008-01-17 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Formylpyridin-2-carbonitril |
| DK2124562T3 (da) * | 2007-03-09 | 2016-08-01 | Second Genome Inc | Bicycloheteroarylforbindelser som p2x7-modulatorer og anvendelser deraf |
| WO2014152996A1 (en) | 2013-03-14 | 2014-09-25 | Cubist Pharmaceuticals, Inc. | Crystalline form of a beta-lactamase inhibitor |
| US9120796B2 (en) | 2013-10-02 | 2015-09-01 | Cubist Pharmaceuticals, Inc. | B-lactamase inhibitor picoline salt |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2585356B1 (fr) * | 1985-07-25 | 1987-10-23 | Roussel Uclaf | Nouveaux derives de l'acide 4-oh quinoleine carboxylique substitues en 2 par deux fonctions hydroxyle eventuellement etherifiees ou esterifiees, leurs procedes de preparation, les nouveaux intermediaires obtenus, leur application comme medicaments et les compositions les renfermant |
| IL110296A (en) * | 1993-07-16 | 1999-12-31 | Smithkline Beecham Corp | Imidazole compounds process for their preparation and pharmaceutical compositions containing them |
| JP3337992B2 (ja) * | 1997-11-04 | 2002-10-28 | ファイザー製薬株式会社 | ５−置換ピコリン酸化合物及びその製造方法 |
-
1998
- 1998-10-07 JP JP33506298A patent/JP3337992B2/ja not_active Expired - Fee Related
- 1998-10-26 US US09/178,949 patent/US6034107A/en not_active Expired - Fee Related
- 1998-10-29 EP EP98308860A patent/EP0926137B1/en not_active Expired - Lifetime
- 1998-10-29 DE DE69823787T patent/DE69823787T2/de not_active Expired - Fee Related
- 1998-10-29 ES ES98308860T patent/ES2218776T3/es not_active Expired - Lifetime
- 1998-10-29 AT AT98308860T patent/ATE266641T1/de not_active IP Right Cessation
- 1998-10-29 DK DK98308860T patent/DK0926137T3/da active
- 1998-10-29 PT PT98308860T patent/PT926137E/pt unknown
- 1998-11-02 CA CA002253080A patent/CA2253080C/en not_active Expired - Fee Related
- 1998-11-03 BR BR9804753-1A patent/BR9804753A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PT926137E (pt) | 2004-07-30 |
| DE69823787D1 (de) | 2004-06-17 |
| CA2253080A1 (en) | 1999-05-04 |
| ATE266641T1 (de) | 2004-05-15 |
| ES2218776T3 (es) | 2004-11-16 |
| US6034107A (en) | 2000-03-07 |
| DE69823787T2 (de) | 2005-05-12 |
| JP3337992B2 (ja) | 2002-10-28 |
| EP0926137B1 (en) | 2004-05-12 |
| BR9804753A (pt) | 2000-05-09 |
| CA2253080C (en) | 2002-07-02 |
| EP0926137A1 (en) | 1999-06-30 |
| JPH11222480A (ja) | 1999-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0926137T3 (da) | Picolinsyrederivater, der er nyttige til behandling af IL-1- og TNF-medierede sygdomme | |
| NL960012I1 (nl) | Gesubstitueerde acylderivaten van 1,2,3,4-tetrahydro-6,7-dimethoxy-3-isochinolinecarbonzuur. | |
| IL136100A0 (en) | Biphenylamidine derivatives, prodrugs thereof and pharmaceutical compositions containing the same | |
| AU2853889A (en) | Therapeutic agents for the treatment of peptic ulcer disease | |
| DK0427518T3 (da) | NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse | |
| ES8204721A1 (es) | Un procedimiento para preparar derivados de halofenil-piri- dilalilamina | |
| EP0802179A4 (en) | DERIVATE SUBSTITUTED AMIDINONAPHTHYLESTER | |
| BG103779A (en) | Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid | |
| ES8506722A1 (es) | Un procedimiento para la preparacion de derivados de -lactama | |
| AP9400608A0 (en) | "New nicotinic acid derivative". | |
| KR910018021A (ko) | 단백질의 글리코실화 진행 억제제 및 그 이용 방법 | |
| HUT70410A (en) | Ketorolac derivative with considerably reduced gastro-intestinal irritation and ulceration | |
| KR960004322A (ko) | 알파-(4-클로로페닐)-4-((4-플루오로페닐)메틸)피페리딘-1-에탄올에스테르,그것의제법및치료학적적용 | |
| MX166479B (es) | Composicion farmaceutica que contiene carbinolimidazoles | |
| JPS6440474A (en) | Novel 2-substituted aminothiazole derivative | |
| ES437192A1 (es) | Procedimiento para la preparacion de nuevos derivados de quinoleina. |